Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.
Press releases published on April 15, 2025
Best Muscle Growth Steroids, Cutting, Anabolic Steroids For Bodybuilding, Is Steroids Testosterone, Do Bodybuilders Use Steroids, Steroids For Muscles (By CrazyBulk)
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- I have worked with many bodybuilders over 30 years, from professionals to beginners. People often ask me what the most effective steroid is for building huge muscles. The answer is Dianabol (also known as Dbol). …
A new Truveta study offers a hopeful sign: Syphilis incidence is down for the first time in decades
GlobeNewswire
·
April 15, 2025
BELLEVUE, WA, April 15, 2025 (GLOBE NEWSWIRE) -- A new study published in the American Journal of Preventive Medicine spotlights a pivotal shift in syphilis transmission patterns across the United States, leveraging Truveta Data to deliver the most timely …
AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit
GlobeNewswire
·
April 15, 2025
BERWYN, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life Sciences, and …
During Oral Cancer Awareness Month, Benevis Raises Visibility for the Importance of Early Detection Through Routine Dental Care
GlobeNewswire
·
April 15, 2025
Atlanta, GA, April 15, 2025 (GLOBE NEWSWIRE) -- During April’s Oral Cancer Awareness Month, Benevis joins its dental industry peers in efforts to highlight the importance of good oral hygiene and proactive risk assessments for the disease. Oral cancer is …
CareSource awarded Nevada Medicaid Managed Care contract
GlobeNewswire
·
April 15, 2025
HENDERSON, Nev., April 15, 2025 (GLOBE NEWSWIRE) -- The Nevada Department of Health and Human Services Division of Health Care Financing and Policy has awarded CareSource, a nationally-recognized, nonprofit managed care organization, a contract for the …
HealthEquity’s Expedited Claims Technology Wins Artificial Intelligence Excellence Awards
GlobeNewswire
·
April 15, 2025
DRAPER, Utah, April 15, 2025 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity"), the nation’s largest Health Savings Account (HSA) administrator, has been recognized by the Business Intelligence Group for its Expedited Claims AI system …
Ezra Appoints Dr. Danna Chung as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Ezra, the healthcare AI startup revolutionizing early cancer detection through full-body MRI screening, today announced the appointment of Dr. Danna Chung as Chief Medical Officer and Medical Director. Dr. Chung …
LiveWorld Releases First-Ever AI Brand Reputation Index for Leading Pharmaceutical Brands
GlobeNewswire
·
April 15, 2025
CAMPBELL, Calif. and NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc. (OTC Markets: LVWD), a pioneer in social-first digital engagement and integrated human-AI solutions, today released its inaugural AI Brand Reputation Index, providing …
NeurAxis to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub on Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025
GlobeNewswire
·
April 15, 2025
CARMEL, Ind., April 15, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and …
Scilex Holding Company Announces Approval of a New Drug Submission (NDS) from the Health Canada’s Pharmaceutical Drugs Directorate, Bureau of Cardiology, Allergy and Neurological Sciences for ELYXYB®’s Acute Treatment of Migraine With or Without Aura i…
GlobeNewswire
·
April 15, 2025
ELYXYB® is a first-line treatment and the only FDA-approved, ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults.1 According to market data from 2018, it was found that migraine was more severe than other types …
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
GlobeNewswire
·
April 15, 2025
RMAT designation was granted based on promising clinical data from the ongoing Phase 1/2 trial of LYL314 in patients with relapsed and/or refractory large B-cell lymphoma. RMAT designation recognizes the potential of LYL314 to address significant unmet …
Confluent Health Honors Physical Therapy Leaders for Service to Patients and Communities
GlobeNewswire
·
April 15, 2025
LOUISVILLE, Ky., April 15, 2025 (GLOBE NEWSWIRE) -- Confluent Health, a nationwide network of physical and occupational therapy companies, recently celebrated local outpatient clinics and clinic directors for demonstrating exceptional leadership, community …
Parexel appoints Charlotte Moser, MD, PhD, MBA as Chief Medical Officer
GlobeNewswire
·
April 15, 2025
DURHAM, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Parexel, one of the world’s largest clinical research organizations (CROs) providing the full range of Phase I to IV clinical development services, today announced the appointment of Charlotte Moser, MD, PhD …
MAPS Announces MDMA-Assisted Therapy Education Event For Ukrainian Mental Health Practitioners
GlobeNewswire
·
April 15, 2025
Nearly 60 Ukrainian therapists will attend the event at no cost, learning fundamentals and best practices for psychedelic-assisted therapies More than 300 practitioners from more than 30 countries have completed MAPS’ International Therapist Education …
BioRestorative to Participate in Benzinga All-Access Show Today to Discuss Recent Achievements of Key Clinical & Regulatory Milestones, and Highlight Commercial Opportunities
GlobeNewswire
·
April 15, 2025
MELVILLE, N.Y., April 15, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to …
Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
GlobeNewswire
·
April 15, 2025
ALAMEDA, Calif. and SAN FRANCISCO, April 15, 2025 (GLOBE NEWSWIRE) -- Vivani Medical, Inc. (NASDAQ: VANI) ("Vivani" or the "Company"), a clinical-stage biopharmaceutical company developing miniature, ultra long-acting drug implants, and Okava …
BioCardia Announces Positive DSMB Review of CardiALLO Allogeneic Cell Therapy for Heart Failure Phase 1/2 Clinical Trial
GlobeNewswire
·
April 15, 2025
Independent Data Safety Monitoring Board (DSMB) recommends that the study proceeds as designed based on 30-day data safety assessment of participants treated in low dosage group. The company plans to progress the trial to enrollment of 39 participants in …
Vivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™
GlobeNewswire
·
April 15, 2025
Kennewick, WA, April 15, 2025 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) is pleased to share new developments in its ongoing human clinical trial in India for RadioGel® Precision Radionuclide Therapy™, an FDA-designated Breakthrough Device for the …
Lifeward Launches Sales of the ReWalk 7 Personal Exoskeleton in U.S. Market
GlobeNewswire
·
April 15, 2025
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, April 15, 2025 (GLOBE NEWSWIRE) -- Seventh generation of industry-leading personal exoskeleton is now available nationwide for individuals with spinal cord injury New and improved features streamline user …
Ashvattha Therapeutics to Present at ARVO, Retina World Congress, and AOS Annual Meeting
GlobeNewswire
·
April 15, 2025
REDWOOD CITY, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in …